1.Jacobsen S, Andersen PH. The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses. Eq Vet Edu. 2007;19:38–46.
2.Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med. 2011;31:51–70.
3.Witkowska-Pilaszewicz OD, Zmigrodzka M, Winnicka A, Miskiewicz A, Strzelec K, Cywinska A. Serum amyloid A in equine health and disease. Equine Vet J. 2019;51:293–98.
4.Christensen M, Jacobsen S, Ichiyanagi T, Kjelgaard-Hansen M. Evaluation of an automated assay based on monoclonal anti-human serum amyloid A (SAA) antibodies for measurement of canine, feline, and equine SAA. Vet J. 2012;194:332–7.
5.Andersen SA, Petersen HH, Ersboll AK, Falk-Ronne J, Jacobsen S. Vaccination elicits a prominent acute phase response in horses. Vet J. 2012;191:199–202.
6.Andreassen SM, Vinther AML, Nielsen SS, Andersen PH, Tnibar A, Kristensen AT, Jacobsen S. Changes in concentrations of haemostatic and inflammatory biomarkers in synovial fluid after intra-articular injection of lipopolysaccharide in horses. BMC Vet Res. 2017;13:182.
7.Busk P, Jacobsen S, Martinussen T. Administration of perioperative penicillin reduces postoperative serum amyloid A response in horses being castrated standing. Vet Surg. 2010;39:638–43.
8.Cohen ND, Chaffin MK, Vandenplas ML, Edwards RF, Nevill M, Moore JN, Martens RJ. Study of serum amyloid A concentrations as a means of achieving early diagnosis of Rhodococcus equi pneumonia. Eq Vet J. 2005;37:212–16.
9.Pollock PJ, Prendergast M, Schumacher J, Bellenger CR. Effects of surgery on the acute phase response in clinically normal and diseased horses. Vet Rec. 2005;156:538–42.
10.Viner M, Mazan M, Bedenice D, Mapes S, Pusterla N. Comparison of serum amyloid A in horses with infectious and noninfectious respiratory diseases. J Eq Vet Sci. 2017;49:11–13.
11.Jacobsen S, Kjelgaard-Hansen M. Evaluation of a commercially available apparatus for measuring the acute phase protein serum amyloid A in horses. Vet Rec. 2008;163:327–30.
12.Schwartz D, Pusterla N, Jacobsen S, Christopher MM. Analytical validation of a new point-of-care assay for serum amyloid A in horses. Equine Veterinary Journal. 2018;50:678–83.
13.Jacobsen S, Kjelgaard-Hansen M, Hagbard Petersen H, Jensen AL. Evaluation of a commercially available human serum amyloid A (SAA) turbidometric immunoassay for determination of equine SAA concentrations. Vet J. 2006;172:315–9.
14.Kjelgaard-Hansen M. Comments on measurement of C-reactive protein in dogs. Vet Clin Pathol. 2010;39:402–03.
15.Cerón JJ, Ohno K, Caldin M. A seven-point plan for acute-pahse protein interpretation in companion animals. Vet J. 2008;177:6–7.
16.Christensen MB, Sorensen JC, Jacobsen S, Kjelgaard-Hansen M. Investigation of the solubility and the potentials for purification of serum amyloid A (SAA) from equine acute phase serum—a pilot study. BMC Res Notes. 2013;6:152.
17.Jacobsen S, Niewold TA, Halling-Thomsen M, Nanni S, Olsen E, Lindegaard C, Andersen PH. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet Immunol Immunopathol. 2006; 110:325–30.
18.Haltmayer E, Schwendenwein I, Licka TF. Course of serum amyloid A (SAA) plasma concentrations in horses undergoing surgery for injuries penetrating synovial structures, an observational clinical study. BMC Vet Res. 2017;13:137.
19.Pihl TH, Nielsen MK, Olsen SN, Leifsson PS, Jacobsen S. Nonstrangulating intestinal infarctions associated with Strongylus vulgaris: Clinical presentation and treatment outcomes of 30 horses (2008–2016). Equine Vet J. 2018;50:474–80.
20.Martinez-Subiela S, Ceron JJ. Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J. 2005; 46:625–9.
21.Stoneham SJ, Palmer L, Cash R, Rossdale PD. Measurement of serum amyloid A in the neonatal foal using a latex agglutination immunoturbidometric assay: determination of the normal range, variation with age and response to disease. Equine Vet J. 2001;33:599–603.
22.Vinther AM, Heegaard PM, Skovgaard K, Buhl R, Andreassen SM, Andersen PH. Characterization and differentiation of equine experimental local and early systemic inflammation by expression responses of inflammation-related genes in peripheral blood leukocytes. BMC Vet Res. 2016;12:83.
23.Jacobsen S, Jensen JC, Frei S, Jensen AL, Thoefner MB. Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study. Equine Vet J. 2005;37:552–6.
24.Kjelgaard-Hansen MJ, Jensen AL: Reference Intervals. In: Weiss DJ, Wardrop KJ, editors.Schalm’s Veterinary Hematology 6. Ames, Iowa: Wiley-Blackwell; 2010. p. 1034–38.
25.Kjelgaard-Hansen M, Jensen AL, Kristensen AT. Internal quality control of a turbidimetric immunoassay for canine serum C-reactive protein based on pooled patient samples. Vet Clin Pathol. 2004;33:139–44.
26.Kjelgaard-Hansen M, Jensen AL. Subjectivity in defining quality specifications for quality control and test validation. Vet Clin Pathol. 2010; 39:134–5.
27.Geffre A, Friedrichs K, Harr K, Concordet D, Trumel C, Braun JP. Reference values: a review. Vet Clin Pathol. 2009;38:288–98.
28.Jensen AL, Kjelgaard-Hansen M. Method comparison in the clinical laboratory. Vet Clin Pathol. 2006; 35:276–86.